As electronic cigarettes become a more popular means of quitting conventional cigarettes, studies pointing to their efficacy are accumulating.
Harm Reduction
The science and policy of minimising risks associated with substance use, high-risk behaviours, and public health challenges — grounded in evidence rather than stigma.
While the amount of money that tobacco companies spent on advertising and promotional expenditures fell by 18 percent between 2006 and 2008, nationwide advertising of smokeless tobacco products actually increased by 55 percent during the same time
We’d like to note that ACSH’s newest publication on tobacco harm reduction will be published in the current issue of Harm Reduction Journal. Authored by Dr.
Two recent studies offer a strong incentive for patients at risk of a heart attack to quit smoking and keep taking their daily dose of aspirin. An Italian study, led by Dr.
This week, ACSH s Jody Manley and Dr.
A New England Journal of Medicine (NEJM) perspective piece on electronic cigarettes (e-cigarettes) would have you believe that FDA-approved cessation methods
In a drug trial that would prove an advance for both HIV prevention and biotech, European scientists are testing the efficacy of an anti-HIV ant
A new study published by the Centers for Disease Control and Prevention (CDC) in Morbidity and Mortality Weekly Report (MMWR)
The parliament in Reykjavik, Iceland is considering some radical tobacco legislation: banning the sale of cigarettes from the usual retail out
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
